These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27349900)

  • 21. Oral immunization of mice with gamma-irradiated Brucella neotomae induces protection against intraperitoneal and intranasal challenge with virulent B. abortus 2308.
    Dabral N; Martha-Moreno-Lafont ; Sriranganathan N; Vemulapalli R
    PLoS One; 2014; 9(9):e107180. PubMed ID: 25225910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.
    Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S
    J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brucella abortusΔcydCΔcydD and ΔcydCΔpurD double-mutants are highly attenuated and confer long-term protective immunity against virulent Brucella abortus.
    Truong QL; Cho Y; Park S; Kim K; Hahn TW
    Vaccine; 2016 Jan; 34(2):237-244. PubMed ID: 26616550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brucella abortus S19 and RB51 vaccine immunogenicity test: Evaluation of three mice (BALB/c, Swiss and CD-1) and two challenge strains (544 and 2308).
    Miranda KL; Dorneles EM; Pauletti RB; Poester FP; Lage AP
    Vaccine; 2015 Jan; 33(4):507-11. PubMed ID: 25498211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
    Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
    Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunization with recombinant GntR plasmid confers protection against Brucella challenge in BALB/c mice.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Han J; Zhang J
    Microb Pathog; 2017 Oct; 111():357-361. PubMed ID: 28916314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
    Goel D; Rajendran V; Ghosh PC; Bhatnagar R
    Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
    Senevirathne A; Hewawaduge C; Lee JH
    Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brucella abortus ΔrpoE1 confers protective immunity against wild type challenge in a mouse model of brucellosis.
    Willett JW; Herrou J; Czyz DM; Cheng JX; Crosson S
    Vaccine; 2016 Sep; 34(42):5073-5081. PubMed ID: 27591954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
    Yang X; Clapp B; Thornburg T; Hoffman C; Pascual DW
    Vaccine; 2016 Oct; 34(44):5290-5297. PubMed ID: 27639282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
    Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S
    Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunization routes and protective efficacy of
    Lalsiamthara J; Won G; Lee JH
    J Vet Sci; 2018 May; 19(3):416-425. PubMed ID: 29366302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of wbkF gene in Brucella abortus RB51WboA leads to increased O-polysaccharide expression and enhanced vaccine efficacy against B. abortus 2308, B. melitensis 16M, and B. suis 1330 in a murine brucellosis model.
    Dabral N; Burcham GN; Jain-Gupta N; Sriranganathan N; Vemulapalli R
    PLoS One; 2019; 14(3):e0213587. PubMed ID: 30856219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a protective protein from stationary-phase exoproteome of Brucella abortus.
    Jain S; Kumar S; Dohre S; Afley P; Sengupta N; Alam SI
    Pathog Dis; 2014 Feb; 70(1):75-83. PubMed ID: 23913725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccination of goats with a combination
    Leya M; Kim WK; Cho JS; Yu EC; Kim YJ; Yeo Y; Lyoo KS; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
    J Vet Sci; 2018 Sep; 19(5):643-652. PubMed ID: 29929362
    [No Abstract]   [Full Text] [Related]  

  • 39. A safe non-toxic Brucella abortus ghosts induce immune responses and confer protection in BALB/c mice.
    Wang S; Li Z; Zhang J; Xi L; Cui Y; Zhang W; Zhang J; Zhang H
    Mol Immunol; 2020 Aug; 124():117-124. PubMed ID: 32559678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Partial protection against Brucella infection in mice by immunization with nonpathogenic alphaproteobacteria.
    Delpino MV; Estein SM; Fossati CA; Baldi PC
    Clin Vaccine Immunol; 2007 Oct; 14(10):1296-301. PubMed ID: 17715332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.